Literature DB >> 18176187

Malignant childhood proptosis: study of 104 cases.

Sameer Bakhshi1, Preetpaul Singh, Nikhil Chawla.   

Abstract

Children < or =18 years with malignant proptosis enrolled in ophthalmic tumor clinic at a tertiary cancer center from July 2003 to December 2006 were retrospectively analyzed. The incidence of proptosis among the pediatric cancer patients was 4.9%. Secondary tumors accounted for majority of cases (n=62, 59.6%) with retinoblastoma (51%) being the commonest cause of proptosis. Fourteen (13.5%) patients presented with bilateral proptosis; all but one had metastatic tumor as underlying cause. Metastatic malignancies had significantly lower hemoglobin and platelet count and higher white blood count. Therefore, careful analysis of symptomatology, hemogram, and those with bilateral proptosis warrant a hematologic work-up before imaging studies and invasive orbital biopsy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18176187     DOI: 10.1097/MPH.0b013e31815a0599

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  4 in total

1.  Granulocytic sarcoma of bladder in an 18-mo-old child with acute myeloid leukemia.

Authors:  C G Delhi Kumar; V Thilagavathy; Thirunavukkarasu Arun Babu
Journal:  Indian J Pediatr       Date:  2014-02-25       Impact factor: 1.967

2.  Compliance in retinoblastoma.

Authors:  Sameer Bakhshi; Shikha Gupta; Varun Gogia; Yaddanapuddi Ravindranath
Journal:  Indian J Pediatr       Date:  2010-03-19       Impact factor: 1.967

3.  Pediatric Oculo-orbital Tumor Characteristics, Imaging and Histopathology Agreement in a Tertiary Level Teaching Hospital, Ethiopia.

Authors:  Semira Abrar Issa; Amal Saleh Nour; Getachew Assefa Neknek
Journal:  Ethiop J Health Sci       Date:  2022-03

4.  Bilateral Proptosis in a Child: A Rare Presentation of Acute Lymphoblastic Leukemia.

Authors:  Pon Ramya Sivaperumal; Sneha Magatha Latha; Sowmiya Narayani; Julius Scott
Journal:  J Ophthalmic Vis Res       Date:  2018 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.